Market Cap

$197.00

Volume

474.5K

Cash and Equivalents

$3.2M

EBITDA

$1.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$49.2M

Profit Margin

89.97%

52 Week High

$0.01

52 Week Low

$0.00

Dividend

N/A

Price / Book Value

0.00

Price / Earnings

-0.00

Price / Tangible Book Value

0.00

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$2.9M

Return on Equity

8.75%

Return on Assets

-1.09

Cash and Short Term Investments

$42.7M

Debt

$15.6M

Equity

$190.2M

Revenue

$54.7M

Unlevered FCF

-$75.2M

Sector

Pharmaceuticals

Category

N/A